Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-31 Purchase | 2023-06-02 5:03 pm | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 2,111 | $1.41 | $2,977 | 9,770 (Direct) | View |
| 2022-11-30 Purchase | 2023-02-03 6:00 pm | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 3 | $1.41 | $4 | 907,659 (Direct) | View |
| 2022-05-31 Purchase | 2022-06-08 9:27 pm | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 7,656 | $1.47 | $11,254 | 7,656 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-01 Option Award | 2023-02-03 6:00 pm | N/A 2033-01-31 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 900,000 | $0 | 907,659 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 9:00 pm | N/A 2032-01-26 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 280,000 | $0 | 280,000 (Direct) | View |
| 2021-09-28 Option Award | 2021-09-30 9:13 pm | N/A 2031-09-28 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 315,000 | $0 | 315,000 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 4:56 pm | N/A 2031-04-14 | Sio Gene Therapies Inc. | SIOX | Sundaram Senthil Vel Director | 42,000 | $0 | 42,000 (Direct) | View |
Ownership | 2021-02-04 5:16 pm | N/A 2030-08-12 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 0 | $0 | 949,197 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 9:06 pm | N/A 2030-04-14 | Axovant Gene Therapies Ltd. | AXGT | Sundaram Senthil Vel Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 6:06 pm | N/A 2029-06-26 | Axovant Gene Therapies Ltd. | AXGT | Sundaram Senthil Vel Director | 18,750 | $0 | 18,750 (Direct) | View |
| 2019-06-07 Disposition | 2019-06-07 4:41 pm | N/A 2029-01-21 | Nightstar Therapeutics plc | NITE | Sundaram Senthil Vel Chief Financial Officer | 108,700 | $10.76 | 0 (Direct) | View |
| 2019-06-07 Disposition | 2019-06-07 4:41 pm | N/A 2028-01-30 | Nightstar Therapeutics plc | NITE | Sundaram Senthil Vel Chief Financial Officer | 60,000 | $11.26 | 0 (Direct) | View |
| 2019-06-07 Disposition | 2019-06-07 4:41 pm | N/A N/A | Nightstar Therapeutics plc | NITE | Sundaram Senthil Vel Chief Financial Officer | 126,886 | $25.5 | 0 (Direct) | View |